Arcadia Biosciences

Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Davis, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Arcadia Biosciences reports positive Q1 results, eyes revenue growth

Arcadia Biosciences delivered strong financial performance in Q1 2024, driven by revenue growth and cost management. The company faces challenges in retail execution but has opportunities for revenue growth through brand expansions and strategic partnerships.

Arcadia Biosciences reports strong Q2 driven by Zola growth

Arcadia Biosciences delivered solid financial performance in Q2 2024 driven by Zola Coconut Water.
Efficient cost-saving measures and strategic asset monetization bolstered profitability.
Challenges include managing increased costs and sustaining growth momentum.
Opportunities lie in expanding Zola brand, diversifying revenue streams, and strategic partnerships.

Arcadia Biosciences reports robust Q3 revenue growth driven by Zola

Arcadia Biosciences delivered strong revenue growth, particularly driven by Zola coconut water sales. Despite challenges in providing forward guidance, the company remains optimistic about Zola's performance and is focused on cost reduction and new product development to drive future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Dallas, TX.

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, and Above Food Corp., an innovative food company leveraging its vertically integrated supply chain to deliver differentiated ingredients and consumer products, announced today that Above Food will purchase the GoodWheatTM brand of better-for-you wheat products from Arcadia for $4 million net. “We see this as the beginning of a partnership between A.

Arcadia Biosciences (RKDA) Announces Sale of GoodWheatTM to Above Food Corp.

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today it has sold its non-GMO Resistant Starch (RS) Durum Wheat trait to longtime partner Corteva Agriscience. Under the terms of the agreement, Arcadia will receive $4 million and retain the right to continue using Resistant Starch Durum in its GoodWheat portfolio of wheat products, including pastas and mac & cheese. Corteva will acq.

Arcadia Biosciences (RKDA) Announces Sale of Resistant Starch Durum Wheat Trait to Corteva Agriscience (CTVA)

Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants T.J. Schaefer - Chief Financial Officer Stan Jacot - President & Chief Executive Officer Conference Call Participants Ben Klieve - Lake Street Operator Thank you for standing by.

Arcadia Biosciences, Inc. (RKDA) Q1 2024 Earnings Call Transcript

Arcadia Biosciences (RKDA) came out with a quarterly loss of $1.78 per share versus the Zacks Consensus Estimate of a loss of $2.52. This compares to loss of $3.83 per share a year ago.

Arcadia Biosciences (RKDA) Reports Q1 Loss, Tops Revenue Estimates

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the first quarter of 2024. “Arcadia continued its positive trajectory in the first quarter of 2024,” said Stan Jacot, president and CEO. “Revenue continues to grow, both sequentially and year-over-year, and we have transitioned the topline to high-quality revenue that generates gross profit acro.

Arcadia Biosciences (RKDA) Announces First Quarter 2024 Financial Results and Business Highlights

Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2024 after market close on May 9, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss first-quarter results and key strategic achievements. Interested participants can join the conference call.

Arcadia Biosciences (RKDA) Announces Date of First Quarter 2024 Financial Results and Business Highlights Conference Call

AMN Healthcare Services

PROG Holdings

AMN, PRG and RKDA have been added to the Zacks Rank #5 (Strong Sell) List on April 22, 2024.

New Strong Sell Stocks for April 22nd

Arcadia Biosciences (RKDA) reports improved top-line results in the fourth quarter of 2023, which is aided by higher GoodWheat and GLA revenues.

Arcadia Biosciences (RKDA) Q4 Earnings Beat Mark, Sales Up Y/Y

Arcadia Biosciences, Inc. (RKDA) Q4 2023 Earnings Call Transcript

Arcadia Biosciences (RKDA) came out with a quarterly loss of $2.48 per share versus the Zacks Consensus Estimate of a loss of $2.68. This compares to loss of $6.31 per share a year ago.

Arcadia Biosciences (RKDA) Reports Q4 Loss, Misses Revenue Estimates

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2023. “We are now at the halfway point of Project Greenfield, our three-year strategic plan to unlock the company's potential and provide a path to profitability, and the results of this focus are unmistakable,” said Stan Jacot, president and CEO. “Arcadia has.

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2023 Financial Results and Business Highlights

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences Inc. (RKDA) will announce its fourth quarter and full year 2023 financial results on March 28, 2024 at 4:30PM ET.

Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2023 Financial Results and Business Highlights Conference Call

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, has expanded the availability of its better-for-you, high fiber GoodWheat™ Mac & Cheese, making the sneaky delicious product available to consumers nationwide on Amazon. Made with noodles crafted from Arcadia's proprietary wheat grain, which is naturally higher in fiber and protein than traditional wheat, GoodWheat Mac & Cheese delivers the.

Arcadia Biosciences (RKDA) Expands GoodWheat™ Mac & Cheese with Nationwide Availability

Cal-Maine Foods

GrowGeneration Corp

Hydrofarm Holdings Group

West Fraser Timber Co. Ltd.

The Zacks Rank for the Agriculture - Products industry paints a gloomy picture. Investors should keep an eye on these five stocks braving the industry headwinds -- West Fraser (WFG), CalMaine Foods (CALM), GrowGeneration (GRWG), Hydrofarm (HYFM) and Arcadia Biosciences (RKDA).

5 Agriculture - Products Stocks to Watch in a Challenging Industry

Andersons

Bunge Global SA

The Agriculture - Products industry is set to gain from solid demand. Stocks like Bunge (BG), Andersons (ANDE) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.

3 Agriculture - Products Stocks to Watch in a Promising Industry

Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants T.J. Schaefer - Chief Financial Officer Stan Jacot - President and Chief Executive Officer Conference Call Participants Dipesh Patel - H.C.

Arcadia Biosciences, Inc. (RKDA) Q3 2023 Earnings Call Transcript

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter of 2023. “Arcadia continues to make excellent progress in executing Project Greenfield, our three-year strategic plan to unlock the company's potential and provide a path to profitability,” said Stan Jacot, president and CEO. “GoodWheatTM pasta and pancake mixes and Zola® cocon.

Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2023 Financial Results and Business Highlights

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter of 2023 after market close on November 9, 2023. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss third-quarter results and key strategic achievements. Interested participants can join the conference.

Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2023 Financial Results and Business Highlights Conference Call

DAVIS, Calif.--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today that Stan Jacot, president and CEO and T.J. Schaefer, CFO, will be participating in two investor conferences during the month of September. H.C. Wainwright 25th Annual Global Investment Conference. Arcadia will be featured as a presenting company at the conference, to be held September 11-13, 2023 at the Lotte Palace Hotel in.

Arcadia Biosciences (RKDA) to Participate in Upcoming Investor Conferences

3 Stocks to Watch in the Thriving Agriculture - Products Industry

Arcadia Biosciences (RKDA) came out with a quarterly loss of $2.64 per share versus the Zacks Consensus Estimate of a loss of $4.92. This compares to loss of $6.80 per share a year ago.

Arcadia Biosciences (RKDA) Reports Q2 Loss, Misses Revenue Estimates

Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants T.J. Schaefer - Chief Financial Officer Stan Jacot - President and Chief Executive Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Dipesh Patel - H.C.

Arcadia Biosciences, Inc. (RKDA) Q2 2023 Earnings Call Transcript

DAVIS, Calif.--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the second quarter and first half of 2023. “Arcadia continues to make progress executing Project Greenfield, our three-year strategic plan to unlock the company's potential and provide a path to profitability,” said Stan Jacot, president and CEO. “Both GoodWheat™ pasta and Zola® coconut w.

Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2023 Financial Results and Business Highlights

Allovir, Inc.

Crocs

Genuine Parts

Duckhorn Portfolio

Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include Crocs (CROX), AlloVir (ALVR), Arcadia Biosciences (RKDA), The Duckhorn Portfolio (NAPA) and Genuine Parts (GPC).

News for Arcadia Biosciences Stock (RKDA)